Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin

NCT03684642 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

908

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision to cancel TRIAL, not related to safety concern.

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Efpeglenatide
DRUG: Dulaglutide
DRUG: Background therapy Metformin

Sponsor

Sanofi

Collaborators

[object Object]